Prevalence of Medication-Related Risks for Falls and Osteoporosis at a Hospital Network: A Post-hoc Analysis

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Orthopaedics

• Publication date

  2016-04-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.17554/IJO.V3I2.1607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PRO‐OSTEO Extend I study (improving osteoporosis management in the acute and rehabilitation settings): multicentre audit

  2015cited by this paper
• Proton-pump inhibitors and risk of fractures: an update meta-analysis

  2015cited by this paper
• Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS)

  2014cited by this paper
• Clinician’s Guide to Prevention and Treatment of Osteoporosis

  2014cited by this paper
• Medication-induced osteoporosis: screening and treatment strategies

  2014cited by this paper
• A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly

  2014cited by this paper
• Medicine Use among Older Australians Before and After Hip Fracture

  2013influential reference
• The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study

  2013influential reference
• Anticholinergic Burden Assessed Using General Practice Electronic Records

  2013cited by this paper
• Osteoporosis costing all Australians: a new burden of disease analysis – 2012 to 2022

  2013cited by this paper
• The effects of risedronate administered in combination with a proton pump inhibitor for the treatment of osteoporosis

  2013cited by this paper
• A population-based case–control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate

  2013cited by this paper
• Fracture Risk and Bone Mineral Density Reduction Associated with Proton Pump Inhibitors

  2012cited by this paper
• Undertreatment of osteoporosis in persons with dementia? A population-based study

  2012cited by this paper
• Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

  2011cited by this paper
• Representation to the accident and emergency department within 1-year of a fractured neck of femur

  2011cited by this paper
• Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors

  2011cited by this paper
• Proton pump inhibitor use and the antifracture efficacy of alendronate.

  2011cited by this paper
• Four‐item fall risk screening tool for subacute and residential aged care: The first step in fall prevention

  2009influential reference
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cited by this paper
• Alcohol and bone

  2007cited by this paper
• Falls prevention revisited: a call for a new approach.

  2004cited by this paper

• Polypharmacy in very elderly hospitalised patients: a single centre study

  2018cites this paper